The Max Foundation (Max) has announced that three patients have started treatment for HER2 negative/HR positive advanced breast cancer (ABC) including CDK4/6 inhibitor therapy in Mozambique through its Max Access Solutions programme.
Trending
- NYSC urges employers to prioritize corps members’ welfare
- Tinubu urges NANS to foster constructive criticism for education growth
- Residents urge action on poor sanitation at Ikorodu garage
- Sony’s move to digital games sparks gaming community concerns
- Tinubu promises clean water for all FCT area councils
- Business confidence weakens in June as rising costs pressure Nigerian firms – CBN survey
- Tinubu’s state police bill gains momentum as Reps adopt executive proposal
- OMO maturities to inject N3.12tr into financial system this week – FMDA
